Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic prioritisation
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (21)
COVID-19 (7)
Type
(
1 selected
)
Type
Guidance (2003)
NICE advice (318)
Quality standard (197)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (21)
Cancer service guidelines (8)
Clinical guidelines (229)
COVID-19 rapid guidelines (3)
Diagnostics guidance (53)
Health technology evaluations (35)
Highly specialised technologies guidance (30)
Interventional procedures guidance (612)
Medical technologies guidance (70)
Medicines practice guidelines (5)
NICE guidelines (338)
Public health guidelines (56)
Safe staffing guidelines (2)
Social care guidelines (70)
Technology appraisal guidance (872)
Apply filters
Showing 1401 to 1425 of 2003
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Aflibercept for treating diabetic macular oedema
TA346
22 July 2015
22 July 2015
Nintedanib for previously treated locally advanced, metastatic, or locally recurrent non‑small‑cell lung cancer
TA347
22 July 2015
22 July 2015
Everolimus for preventing organ rejection in liver transplantation
TA348
22 July 2015
22 July 2015
Secukinumab for treating moderate to severe plaque psoriasis
TA350
22 July 2015
22 July 2015
Cangrelor for reducing atherothrombotic events in people undergoing percutaneous coronary intervention or awaiting surgery requiring interruption of anti‑platelet therapy (terminated appraisal)
TA351
22 July 2015
22 July 2015
Insertion of an epiretinal prosthesis for retinitis pigmentosa
IPG519
26 June 2015
26 June 2015
Radiofrequency ablation for gastric antral vascular ectasia
IPG520
26 June 2015
26 June 2015
Suture fixation of acute disruption of the distal tibiofibular syndesmosis
IPG521
26 June 2015
26 June 2015
Ultrasound‑enhanced, catheter‑directed thrombolysis for deep vein thrombosis
IPG523
26 June 2015
26 June 2015
Ultrasound‑enhanced, catheter‑directed thrombolysis for pulmonary embolism
IPG524
26 June 2015
26 June 2015
Electrotherapy for the treatment of haemorrhoids
IPG525
26 June 2015
26 June 2015
Implantation of a sphenopalatine ganglion stimulation device for chronic cluster headache
IPG527
26 June 2015
26 June 2015
Omalizumab for previously treated chronic spontaneous urticaria
TA339
8 June 2015
8 June 2015
Vedolizumab for treating moderately to severely active ulcerative colitis
TA342
5 June 2015
5 June 2015
Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism
TA341
4 June 2015
4 June 2015
Lower urinary tract symptoms in men: management
CG97
23 May 2010
3 June 2015
Obinutuzumab in combination with chlorambucil for untreated chronic lymphocytic leukaemia
TA343
2 June 2015
2 June 2015
Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challenges
NG11
29 May 2015
29 May 2015
Violence and aggression: short-term management in mental health, health and community settings
NG10
28 May 2015
28 May 2015
Implantation of a left ventricular assist device for destination therapy in people ineligible for heart transplantation
IPG516
27 March 2015
27 March 2015
Insertion of endobronchial nitinol coils to improve lung function in emphysema
IPG517
27 March 2015
27 March 2015
Implantation of a duodenal–jejunal bypass liner for managing type 2 diabetes
IPG518
27 March 2015
27 March 2015
Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome
TA335
25 March 2015
25 March 2015
Empagliflozin in combination therapy for treating type 2 diabetes
TA336
25 March 2015
25 March 2015
Rifaximin for preventing episodes of overt hepatic encephalopathy
TA337
25 March 2015
25 March 2015
Previous page
1
…
55
56
Current page
57
58
59
…
81
Page
57
of
81
Next page
Results per page
10
25
50
All
Back to top